nach oben

Current Reviews in Musculoskeletal Medicine

Erschienen in:

01.09.2011

Non-surgical treatment of osteoarthritis-related pain in the elderly

verfasst von: Saulat Mushtaq, Rabeea Choudhary, Carla R. Scanzello

Erschienen in: Current Reviews in Musculoskeletal Medicine | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Osteoarthritis (OA), the third most common diagnosis in the elderly [1], causes significant pain leading to disability and decreased quality of life in subjects 65 years and older [2]. Traditionally, clinicians have relied heavily on the use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat the pain of OA, as numerous studies have proven these agents to be effective. The cardiovascular, gastrointestinal, renal and hepatic toxicities of NSAIDs have limited their use, particularly in the elderly. Acetaminophen has been recommended as initial therapy due to relative safety. Several other topical, oral and intra-articular agents are available today, with use limited by efficacy and side effect profiles. Many non-pharmacologic approaches are available but underused, and may be attractive choices to avoid poly-pharmacy in older patients. We will attempt to highlight the evidence behind available non-surgical therapies for OA while paying specific attention to issues in geriatric patients.

Felson DT, Lawrence RC, Dieppe PA, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. 2000;133:635–46.PubMed

Mili F, Helmick CG, Moriarty DG. Health related quality of life among adults reporting arthritis: analysis of data from the behavioral risk factor surveillance system, US, 1996–99. J Rheumatol. 2003;30:160–6.PubMed

Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84:351–8.PubMedCrossRef

Buckwalter JA, Saltzman C, Brown T: The impact of osteoarthritis: implications for research. Clin Orthop Relat Res 2004;(427 Suppl):S6–15.

Tan AL, Grainger AJ, Tanner SF, et al. High-resolution magnetic resonance imaging for the assessment of hand osteoarthritis. Arthritis Rheum. 2005;52:2355–65.PubMedCrossRef

Burr DB, Radin EL. Microfractures and microcracks in subchondral bone: are they relevant to osteoarthrosis? Rheum Dis Clin North Am. 2003;29:675–85.PubMedCrossRef

•• Hawker G: Experiencing painful osteoarthritis: what have we learned from listening? Curr Opin Rheumatol 2009;21:507. An interesting review of our current understanding that osteoarthritis pain is multidimensional, reflecting the influence of biological, psychological and social factors. Suggest that discussion of OA pain should include attention to words people use to describe pain to help with mechanism and evidence based treatment.

Iwasa H, Yoshida Y, Kumagai S, et al. Depression status as a reliable predictor of functional decline among Japanese community-dwelling older adults: a 12-year population-based prospective cohort study. Int J Geriatr Psychiatry. 2009;24:1192–200.PubMedCrossRef

Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905–15.

10.

•• Zhang W, Nuki G, Moskowitz RW, et al.: OARSI recommendations for the management of hip and knee osteoarthritis: Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010;18:476–499. A good synthesis of cumulative evidence for management of hip and knee OA published up to 2009; includes evidence on pharmacologic, non-pharmacologic agents and surgical options. Of the three published treatment guidelines referenced in this review, the OARSI guidelines are the most recently updated.

11.

Kerrigan DC, Lelas JL, Goggins J, et al. Effectiveness of a lateral-wedge insole on knee varus torque in patients with knee osteoarthritis. Arch Phys Med Rehabil. 2002;83:889–93.PubMedCrossRef

12.

Maillefert JF, Hudry C, Baron G, et al. Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis: a prospective randomized controlled study. Osteoarthr Cartil. 2001;9:738–45.PubMedCrossRef

13.

Pham T, Maillefert JF, Hudry C, et al. Laterally elevated wedged insoles in the treatment of medial knee osteoarthritis: a two-year prospective randomized controlled study. Osteoarthr Cartil. 2004;12:46–55.PubMedCrossRef

14.

Butler RJ, Barrios JA, Royer T. Effect of laterally wedged foot orthoses on rearfoot and hip mechanics in patients with medial knee osteoarthritis. Prosthet Orthot Int. 2009;33:107–16.PubMedCrossRef

15.

Shimada S, Kobayashi S, Wada M, et al. Effects of disease severity on response to lateral wedged shoe insole for medial compartment knee osteoarthritis. Arch Phys Med Rehabil. 2006;87:1436–41.PubMedCrossRef

16.

Baker K, Goggins J, Xie H, et al. A randomized crossover trial of a wedged insole for treatment of knee osteoarthritis. Arthritis Rheum. 2007;56:1198–203.PubMedCrossRef

17.

Hinman RS, Payne C, Metcalf BR, et al. Lateral wedges in knee osteoarthritis: what are their immediate clinical and biomechanical effects and can these predict a three-month clinical outcome? Arthrit Care Res. 2008;59:408–15.CrossRef

18.

Shakoor N, Block JA. Walking barefoot decreases loading on the lower extremity joints in knee osteoarthritis. Arthritis Rheum. 2006;54:2923–7.PubMedCrossRef

19.

• Shakoor N, Sengupta M, Foucher KC, et al.: Effects of common footwear on joint loading in osteoarthritis of the knee. Arthrit Care Res 2010;62:917–923. Nicely designed study demonstrating that everyday shoes like clogs and stability shoes increase joint load compared with bare foot walking.

20.

Shakoor N, Lidtke RH, Sengupta M, et al. Effects of specialized footwear on joint loads in osteoarthritis of the knee. Arthrit Care Res. 2008;59:1214–20.CrossRef

21.

Kirkley A, Webster-Bogaert S, et al. The effect of bracing on varus gonarthrosis. J Bone Joint Surg Am. 1999;81:539–48.PubMed

22.

Sharma L, Pai YC, Holtkamp K, et al. Is knee joint proprioception worse in the arthritic knee versus the unaffected knee in unilateral knee osteoarthritis? Arthritis Rheum. 1997;40:1518–25.PubMedCrossRef

23.

Richards JD, Sanchez-Ballester J, Jones RK, et al. A comparison of knee braces during walking for the treatment of osteoarthritis of the medial compartment of the knee. J Bone Joint Surg Br. 2005;87:937–9.PubMedCrossRef

24.

Chuang SH, Huang MH, Chen TW, et al. Effect of knee sleeve on static and dynamic balance in patients with knee osteoarthritis. Kaohsiung J Med Sci. 2007;23:405–11.PubMedCrossRef

25.

Brouwer RW, van Raaij TM, Verhaar JA, et al. Brace treatment for osteoarthritis of the knee: a prospective randomized multi-centre trial. Osteoarthr Cartil. 2006;14:777–83.PubMedCrossRef

26.

Brouwer GM, Tol AWV, Bergink AP, et al. Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum. 2007;56:1204–11.PubMedCrossRef

27.

•• Warden SJ, Hinman RS, Watson MA, et al.: Patellar taping and bracing for the treatment of chronic knee pain: A systematic review and meta-analysis. Arthrit Care Res 2008;59:73–83. Evaluation of 13 trials investigating the value of taping and bracing, concluding that medially directed force on the patella produces significant reduction in pain in varus malalignment.

28.

•• Hunter DJ, Harvey W, Gross KD, et al: A randomized trial of patellofemoral bracing for treatment of patellofemoral osteoarthritis. Osteoarthritis Cartilage 2011, (Epub ahead of print) doi:10.1016/j.joca.2010.12.010. A recent and well designed trial of patellar bracing in patients with patellofemoral OA. The authors did not demonstrate a significant effect on pain with one type of commercially available brace. However, whether this specific brace sufficiently modified patellar tracking was not evaluated.

29.

Slemenda C, Brandt KD, Heilman DK, et al. Quadriceps weakness and osteoarthritis of the knee. Ann Intern Med. 1997;127:97–104.PubMed

30.

Van Baar ME, Assendelft WJ, Dekker J, et al. Effectiveness of exercise therapy in patients with osteoarthritis of the hip or knee: a systematic review of randomized clinical trials. Arthritis Rheum. 1999;42:1361–9.PubMedCrossRef

31.

Segal NA, Torner JC, Felson D, et al. Effect of thigh strength on incident radiographic and symptomatic knee osteoarthritis in a longitudinal cohort. Arthrit Care Res. 2009;61:1210–17.CrossRef

32.

Zhao D, Banks SA, Mitchell KH, et al. Correlation between the knee adduction torque and medial contact force for a variety of gait patterns. J Orthop Res. 2007;25:789–97.PubMedCrossRef

33.

Lim B, Hinman RS, Wrigley TV, et al. Does knee malalignment mediate the effects of quadriceps strengthening on knee adduction moment, pain, and function in medial knee osteoarthritis? A randomized controlled trial. Arthrit Care Res. 2008;59:943–51.CrossRef

34.

Bennell KL, Hunt MA, Wrigley TV, et al. Hip strengthening reduces symptoms but not knee load in people with medial knee osteoarthritis and varus malalignment: a randomised controlled trial. Osteoarthr Cartil. 2010;18:621–8.PubMedCrossRef

35.

Thorp LE, Wimmer MA, Foucher KC, et al. The biomechanical effects of focused muscle training on medial knee loads in OA of the knee: a pilot, proof of concept study. J Musculoskelet Neuronal Interact. 2010;10:166–73.PubMed

36.

• Jansen MJ, Viechtbauer W, Lenssen AF, et al.: Strength training alone, exercise therapy alone, and exercise therapy with passive manual mobilization each reduce pain and disability in people with knee osteoarthritis: a systematic review. J Physiother 2011;57:11–20. Exercise therapy with manual mobilization appears superior to strength training or exercise therapy alone even though all three modalities improve pain and physical function.

37.

Mangami I, Cesari M, Kritchevky SB et al. Physcial exercise and comorbidity. Results from the Fitness and Arthritis in Seniors Trial (FAST). 2006;18: 374–80.

38.

Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005;12:46–55.PubMedCrossRef

39.

Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence base approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145–55.PubMedCrossRef

40.

Towheed TE, Maxwell L, Judd MG, et al.: Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006;CD004257.

41.

Chan AT, Manson JE, Albert CM, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation. 2006;113:1578–87.PubMedCrossRef

42.

• Rahme E, Barkun A, Nedjar H, et al.: Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol 2008;103:872–882. Combination therapy of acetaminophen and NSAID may compound GI toxicity.

43.

Curhan GC, Knight EL, Rosner B, et al. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med. 2004;164:1519–24.PubMedCrossRef

44.

Bjordal JM, Klovning A, Ljunggren AE, et al. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomised placebo-controlled trials. Eur J Pain. 2007;11:125–38.PubMedCrossRef

45.

McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA. 2006;296:1633–44.PubMedCrossRef

46.

Geba GP, Weaver AL, Polis AB, Dixon ME, et al. Vioxx, Acetaminophen, Celecoxib Trial (VACT) Group: efficacy of rofecoxib, celecoxib and acetaminophen in osteoarthritis of the knee: a randomized trial. JAMA. 2002;287:64–71.PubMedCrossRef

47.

Rahme E, Barkun AN, Toubouti Y, et al. Do proton-pump inhibitors confer additional gastrointestinal protection in patients given celecoxib? Arthrit Care Res. 2007;57:748–55.CrossRef

48.

Barkin RL. Extended-release tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain. Am J Ther. 2008;15:157–66.PubMedCrossRef

49.

Cepeda MS, Camargo F, Zea C, et al. Tramadol for osteoarthritis: a systematic review and metaanalysis. J Rheumatol. 2007;34:543–55.PubMed

50.

Vorsanger G, Xiang J, Jordan D, et al.: Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients. Clin Ther 2007;(29 Suppl):2520–2535.

51.

Sansone RA, Sansone LA. Tramadol: Seizures, serotonin syndrome, and coadministered antidepressants. Psychiatry (Edgmont). 2009;6:17–21.

52.

• Nuesch E, Rutjes AW, Husni E, et al.: Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009;4:CD003115. As there are numerous small studies on opioid agents with a myriad of limitations, this updated systemic review is helpful in synthesizing the available evidence.

53.

Furlan AD, Sandoval JA, Mailis-Gagnon A, et al. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589–94.PubMedCrossRef

54.

Sullivan MD, Bentley S, Fan M-Y, Gardner G. A single-blind, placebo run-in study of duloxetine for activity-limiting osteoarthritis pain. J Pain. 2009;10:208–13.PubMedCrossRef

55.

Chandran P, Pai M, Blomme EA, et al. Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis. Eur J Pharmacol. 2009;613:39–45.PubMedCrossRef

56.

• Chappell AS, Desaiah D, Liu-Seifert H, et al.: A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Practice 2010;11: 33–41. This is the latest publication on the results from a 13 week RCT of duloxetine for the treatment of knee OA pain. This agent is one of the most recent (November 2010) to receive FDA approval for the treatment of OA-related pain.

57.

Brunton S, Wang F, Edwards SB, et al. Profile of adverse events with duloxetine treatment. Drug Saf. 2010;33:393–407.PubMedCrossRef

58.

Lin J, Zhang W, Jones A. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ. 2004;329:324.PubMedCrossRef

59.

Biswal S, Medhi B, Pandhi P. Longterm efficacy of topical nonsteroidal anti-inflammatory drugs in knee osteoarthritis: meta-analysis of randomized placebo controlled clinical trials. J Rheumatol. 2006;33:1841–4.PubMed

60.

• Altman RD, Dreiser RL, Fisher CL, et al.: Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009;36:1991–1999. An RCT on one of the more recently FDA approved topical agents used to treat OA. This study focuses specifically on hand OA, which is an often overlooked source of pain and disability in the elderly.

61.

Simon LS, Grierson LM, Naseer Z, et al. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain. 2009;143:238–45.PubMedCrossRef

62.

Gammaitoni AR, Galer BS, Onawola R, et al.: Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the neuropathic pain scale. Curr Med Res Opin 2004;(20 Suppl 2): S13–9.

63.

Burch F, Codding C, Patel N, et al. Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients: a prospective, multicenter, open-label effectiveness trial. Osteoarthr Cartil. 2004;12:253–5.PubMedCrossRef

64.

Bellamy N, Campbell J, Robinson V, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;2:CD005328.PubMed

65.

Micu MC, Bogdan GD, Fodor D. Steroid injection for hip osteoarthritis: efficacy under ultrasound guidance. Rheumatology (Oxford). 2010;49:1490–4.CrossRef

66.

Chevalier X, Jerosch J, Goupille P, et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial. Ann Rheum Dis. 2010;69:113–19.PubMedCrossRef

67.

Miltner O, Schneider U, Siebert CH, et al. Efficacy of intraarticular hyaluronic acid in patients with osteoarthritis: a prospective clinical trial. Osteoarthr Cartil. 2002;10:680–6.PubMedCrossRef

68.

Dougados M, Nguyen M, Listrat V, et al. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthr Cartil. 1993;1:97–103.PubMedCrossRef

69.

Bellamy N, Campbell J, Robinson V, et al.: Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006;CD005321.

70.

Lussier A, Cividino AA, McFarlane CA, et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol. 1996;23:1579–85.PubMed

71.

Lohmander LS, Dalen N, Englund G, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomized double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis. 1996;55:424–31.PubMedCrossRef

72.

Brander VA, Gomberawalla A, Chambers M, Bowen M, Nuber G. Efficacy and safety of hylan G-F for symptomatic glenohumeral osteoarthritis: a prospective, pilot study. PMR. 2010;2:259–67.

73.

Miglore A, Massafra U, Bizzi E, et al. Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther. 2009;11:R183.CrossRef

74.

Mandl LA, Hotchkiss RN, Adler RS, et al. Injectable hyaluronan for the treatment of carpometacarpal osteoarthritis: open label pilot trial. Curr Med Res Opin. 2009;15:2103–8.CrossRef

75.

Disla E, Infante R, Fahmy A, et al. Recurrent acute calcium pyrophosphate dihydrate arthritis following intraarticular hyaluronate injection. Arthritis Rheum. 1999;42:1302–3.PubMedCrossRef

76.

Luzar MJ, Altawil B. Pseudogout following intraarticular injection of sodium hyaluronate. Arthritis Rheum. 1998;41:939–40.PubMedCrossRef

77.

Ernst E. Complementary or alternative therapies for osteoarthritis. Nat Clin Pract Rheumatol. 2006;2:74–80.PubMedCrossRef

78.

Clegg DO, Reda DJ, Harris CL, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354:795–808.PubMedCrossRef

79.

Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007;56:555–67.PubMedCrossRef

80.

Biggee BA, Blinn CM, McAlindon TE, et al. Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness. Ann Rheum Dis. 2006;65:222–6.PubMedCrossRef

81.

Sun BH, Wu CW, Kalunian KC. New developments in osteoarthritis. Rheum Dis Clin North Am. 2007;33:135–48.PubMedCrossRef

82.

Towheed TE, Maxwell L, Anastassiades TP, et al.: Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev 2005;CD002946.

83.

• Sawitzke AD, Shi H, Finco MF, et al.: Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis 2010;69:1459–1464. The two-year outcomes from the GAIT trial, the large, NIH funded study evaluating Glucosamine and Chondroitin supplements on knee OA. Glucosamine, Chondroitin or the combination of these did not reduce OA pain significantly.

84.

Goekoop RJ, Kloppenburg M, Kroon HM, et al. Low innate production of interleukin-1β and interleukin-6 is associated with the absence of osteoarthritis in old age. Osteoarthr Cartil. 2010;18:942–7.PubMedCrossRef

85.

• Chevalier X, Goupille P, Beaulieu AD, et al.: Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthrit Care Res 2009;61:344–52. A 12-week RCT of this agent, originally developed to treat Rheumatoid Arthritis. In this study, anakinra was used as a single injection intra-articularly, and failed to show improvement in OA pain. Although results were disappointing, IL-1 blockade using longer-acting agents and different regimens are currently being studied, and may become available in the future.

86.

Watson JJ, Allen SJ, Dawbarn D. Targeting nerve growth factor in pain: what is the therapeutic potential? BioDrugs. 2008;22:349–59.PubMedCrossRef

87.

•• Lane NE, Schnitzer TJ, Birbara CA, et al.: Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med 2010;363:1521–1531. Tanezumab™, a novel agent targeted nerve-growth factor, produced significant pain reduction compared with placebo but caused headaches, URIs and hypoesthesias. Although initially promising,recent concerns that this agent may have hastened the need for joint replacement in study patients resulted in the discontinuation of this trial.

88.

• Dekker J, van Dijk GM, Veenhof C: Risk factors for functional decline in osteoarthritis of the hip or knee. Curr Opin Rheumatol 2009;21:520–524. A useful review of the risk factors for functional decline in the elderly, which include physical impairments from osteoarthritis (pain, stiffness, reduced muscle strength, joint instability, proprioceptive inaccuracy, poor balance and impaired range of motion), as well as cognitive and visual impairments, comorbidities, psychological and social factors, health behaviors and socio-demographic factors. This can be useful for patients and physicians and encourages the approach of treating the “whole patient”, not just the osteoarthritis.

Titel: Non-surgical treatment of osteoarthritis-related pain in the elderly
verfasst von: Saulat Mushtaq
Rabeea Choudhary
Carla R. Scanzello
Publikationsdatum: 01.09.2011
Verlag: Current Science Inc.
Erschienen in: Current Reviews in Musculoskeletal Medicine / Ausgabe 3/2011
Elektronische ISSN: 1935-9748
DOI: https://doi.org/10.1007/s12178-011-9084-9

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2011

Direct anterior approach for total hip arthroplasty using the fracture table

Risk factors for incident osteoarthritis of the hip and knee

Musculoskeletal education in US medical schools: lessons from the past and suggestions for the future

Robotic assisted total hip arthroplasty using the MAKO platform

Report of an international symposium on narrowing the Gap in the treatment and study of SLE worldwide: minimum best practices in the management and monitoring of moderate to severe SLE and improving outcomes in constrained environments

Treating rheumatoid arthritis to target: an international initiative